Christopher Nielson1, Yiqing Huang1, C Amanda Kull1, Albert H Park2. 1. Division of Otolaryngology - Head and Neck Surgery, University of Utah School of Medicine, Salt Lake City, UT, USA. 2. Division of Otolaryngology - Head and Neck Surgery, University of Utah School of Medicine, Salt Lake City, UT, USA. Electronic address: Albert.Park@hsc.utah.edu.
Abstract
OBJECTIVE: To determine whether a community engagement approach can provide feedback for implementation of valuable measures to improve the outcome of a clinical trial. METHODS: Review of the results from a Community Engagement Studio (CE Studio) for the ValEAR trial: an NIH-funded, multi-institutional study designed to research the efficacy of valganciclovir in the treatment of congenital cytomegalovirus (cCMV)-induced hearing loss. Participants were given information about the trial then asked a series of questions to assess their input on the merits or weaknesses affecting their participation in the trial. RESULTS:Thirteen parents whose children have congenital CMV infection were recruited for the CE Studio. The overall theme from the responses was a desire to advance the field but a need to clearly understand the risks and benefits of participation. Many requested more educational resources, more printed materials, or greater access to researchers if questions arose. Many welcomed having patient stories and information displayed in a dedicated website or through social media. CONCLUSION: This community engagement approach provided useful feedback from families similar to those expected to be potential enrollees in the CMV ValEAR trial. In response to parental comments, two educational videos were created: one on the general topic of cCMV and the other specific to the CMV ValEAR trial. Researchers who wish to optimize their clinical trial's success should consider incorporating a CE Studio into their study design. Published by Elsevier B.V.
RCT Entities:
OBJECTIVE: To determine whether a community engagement approach can provide feedback for implementation of valuable measures to improve the outcome of a clinical trial. METHODS: Review of the results from a Community Engagement Studio (CE Studio) for the ValEAR trial: an NIH-funded, multi-institutional study designed to research the efficacy of valganciclovir in the treatment of congenital cytomegalovirus (cCMV)-induced hearing loss. Participants were given information about the trial then asked a series of questions to assess their input on the merits or weaknesses affecting their participation in the trial. RESULTS: Thirteen parents whose children have congenital CMV infection were recruited for the CE Studio. The overall theme from the responses was a desire to advance the field but a need to clearly understand the risks and benefits of participation. Many requested more educational resources, more printed materials, or greater access to researchers if questions arose. Many welcomed having patient stories and information displayed in a dedicated website or through social media. CONCLUSION: This community engagement approach provided useful feedback from families similar to those expected to be potential enrollees in the CMV ValEAR trial. In response to parental comments, two educational videos were created: one on the general topic of cCMV and the other specific to the CMV ValEAR trial. Researchers who wish to optimize their clinical trial's success should consider incorporating a CE Studio into their study design. Published by Elsevier B.V.
Entities:
Keywords:
Clinical trials; Community engagement; Otolaryngology research
Authors: Daniel W Byrne; Italo Biaggioni; Gordon R Bernard; Tara T Helmer; Leslie R Boone; Jill M Pulley; Terri Edwards; Robert S Dittus Journal: Acad Med Date: 2012-08 Impact factor: 6.893
Authors: Alexander G Fiks; A Russell Localio; Evaline A Alessandrini; David A Asch; James P Guevara Journal: Pediatrics Date: 2010-07-12 Impact factor: 7.124
Authors: Nancy S Sung; William F Crowley; Myron Genel; Patricia Salber; Lewis Sandy; Louis M Sherwood; Stephen B Johnson; Veronica Catanese; Hugh Tilson; Kenneth Getz; Elaine L Larson; David Scheinberg; E Albert Reece; Harold Slavkin; Adrian Dobs; Jack Grebb; Rick A Martinez; Allan Korn; David Rimoin Journal: JAMA Date: 2003-03-12 Impact factor: 56.272
Authors: Yvonne A Joosten; Tiffany L Israel; Neely A Williams; Leslie R Boone; David G Schlundt; Charles P Mouton; Robert S Dittus; Gordon R Bernard; Consuelo H Wilkins Journal: Acad Med Date: 2015-12 Impact factor: 6.893